https://www.selleckchem.com/pr....oducts/crt0066101-di
ossible framework to better understand the cognitive origin of IAH in this patient population. Previous studies have found reduced concentrations of both leptin and resistin after glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment; however, the evidence in this field is inconclusive. Therefore, the aim of this meta-analysis of randomized controlled trials was to evaluate the effect of GLP-1 RA on both leptin and resistin levels. The present systematic review and meta-analysis included randomized controlled
Like
Comment
Share
